EEF2-inactivating toxins engage the NLRP1 inflammasome and promote epithelial barrier disruption per Pinilla, Miriam, Mazars, Raoul, Vergé, Romain, Gorse, Leana, Paradis, Margaux, Suire, Bastien, Santoni, Karin, Robinson, Kim Samirah, Toh, Gee Ann, Prouvensier, Laure, Leon-Icaza, Stephen Adonai, Hessel, Audrey, Péricat, David, Murris, Marlène, Guet-Revillet, Hélène, Henras, Anthony, Buyck, Julien, Ravet, Emmanuel, Zhong, Franklin, Cougoule, Céline, Planès, Rémi, Meunier, Etienne

Matèries: Obtenir text complet

Elongation factor 2 in cancer: a promising therapeutic target in protein translation per Xuechao Jia, Chuntian Huang, Fangfang Liu, Zigang Dong, Kangdong Liu

Matèries: “…Elongation factor 2…”
Obtenir text complet

2,4-disubstituted 6-fluoroquinolines as potent antiplasmodial agents: QSAR, homology modeling, molecular docking and ADMET studies per Gideon A. Shallangwa, PhD, Aliyu W. Mahmud, MSc, Adamu Uzairu, PhD, Muhmmad T. Ibrahim, PhD

Matèries: Obtenir text complet

Silencing eEF2K combined with sodium tanshinone ⅡA sulfonate synergistically inhibit proliferation of human lung adenocarcinoma cell line A549 per WANG Bu, YUAN Sheng-fang, ZHANG Chang-hong, YUAN Cheng, HUANG Pan-deng, ZHANG Zhi-hua, ZHAO Jian-qing

Matèries: “…lung adenocarcinoma|eukaryotic elongation factor 2 kinase|sodium tanshinone ⅱa sulfonate|proliferation|invasion…”
Obtenir text complet